Empowering Timely & Affordable Drug-Diagnostic Access Across APAC Through Harmonized Trial Management, Policy Shaping, & Testing Adoption
With rising demand for targeted therapies and testing access, the Asia-Pacific region is becoming a rising player in the co-development and commercialization of drug-diagnostic strategies. In under a year, Singapore has accelerated public-private partnerships to scale genomic testing, China has expanded national reimbursement for liquid biopsies, and Japan has refined its regulatory framework for companion diagnostic approvals.
Returning for its second year, the World Liquid Biopsy & Companion Diagnostics Summit APAC will unite 100+ leaders across biopharma, diagnostics, regulation, and healthcare to drive the co-development and commercialization of affordable, scalable, and timely testing solutions.
Spanning oncology to neurology, chronic and rare diseases, join this APAC-dedicated forum addressing the full drug-diagnostic co-development journey, where precision partnerships are formed, regional strategies aligned, and precision medicine innovation accelerated for improved patient access across the region.
Speakers
演讲者 | 講演者 | penceramah
Attending Companies Include
与会公司 | 参加企業 | Syarikat yang Hadir
Dedicated Room Block
Room Block Available
We are pleased to announce that for the 2nd World CDx & LBx Summit APAC we have a dedicated room block at the conference hotel, voco Orchard Singapore by IHG
We have a discounted nightly room rate of S$336 from 10th to the 12th of November.
If you wish to extend your stay, please reach out to janna.lim@ihg.com who can make these necessary updates.
Reservations must be made by Tuesday 28th October which is the cutoff date. However, please note due to high demand, rooms may sell out before the cutoff date, so we do recommend you book your accommodation sooner rather than later.
Please email Mollie Hookway at mollie.hookway@hansonwade.com if you have any questions or queries regarding the room block.